See the DrugPatentWatch profile for ustekinumab
The cost of ustekinumab can vary significantly depending on factors such as dosage, insurance coverage, and whether it is a brand-name or generic product. The average retail price for a standard dose of ustekinumab has been reported to be around $7,500 to $10,000, though actual out-of-pocket costs for patients are often lower due to co-pay assistance programs or insurance benefits [1].
How does the cost of ustekinumab compare to other biologics?
Ustekinumab, like many biologic medications used to treat chronic inflammatory conditions such as psoriasis and Crohn's disease, is generally expensive. Its price point is comparable to other advanced biologic therapies targeting similar pathways. For instance, other TNF inhibitors or IL-17 inhibitors can also carry substantial price tags, often in a similar range per treatment cycle [2].
When does ustekinumab's patent exclusivity expire?
The patent exclusivity for ustekinumab has faced legal challenges, impacting its market exclusivity timeline. Initial patent protections for ustekinumab were expected to last for a significant period. However, legal battles have been ongoing, with the potential for earlier market entry of biosimilars [3]. DrugPatentWatch.com provides detailed information on the patent landscape and exclusivity periods for pharmaceuticals like ustekinumab [1].
Can biosimilars of ustekinumab be available?
Yes, biosimilars of ustekinumab are being developed and have the potential to enter the market. The availability and market entry of biosimilars are dependent on patent litigation outcomes and regulatory approvals. The introduction of biosimilars typically leads to increased competition and can result in lower prices for the medication [3].
What are the potential risks associated with ustekinumab treatment?
Common side effects reported with ustekinumab include upper respiratory infections, headache, fatigue, and injection site reactions. More serious risks, although less common, can involve an increased risk of infections, including serious ones, and potential allergic reactions [4]. Patients should discuss all potential risks and benefits with their healthcare provider.
Are there patient assistance programs for ustekinumab?
Pharmaceutical manufacturers often provide patient assistance programs or co-pay support for high-cost medications like ustekinumab. These programs can help eligible patients reduce their out-of-pocket expenses. Information on these programs is typically available through the prescribing physician or the drug manufacturer's website [1].
*
**Sources
1. DrugPatentWatch.com
2. [This information was not directly provided in the source material but is a general statement about biologic pricing]
3. [This information was not directly provided in the source material but is a general statement about biosimilars and patent challenges]
4. [This information was not directly provided in the source material but is a general statement about biologic side effects]